Loading stock data…
The Pennant Group (PNTG)
$41.16+1.35 (+3.39%)
Market ClosedLast close Jul 24
The Pennant Group, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
The Pennant Group, Inc. in the Healthcare sector is trading at $41.16 with a market capitalization of $1.2B. Wall Street consensus targets $45.00 (6 analysts), implying a +9.3% move over the next 12 months. The stock is currently near its 52-week high of $42.55, remaining 32.9% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +9.3% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $285.36M↓ | $289.32M↑ | $229.04M↑ | $219.50M↑ | $209.84M |
| Gross Profit | $39.60M↑ | $39.27M↑ | $31.55M↑ | $30.30M↑ | $29.38M |
| Operating Income | $17.30M↓ | $17.57M↑ | $10.19M↓ | $10.48M↓ | $12.65M |
| Net Income | $8.52M↓ | $8.64M↑ | $6.08M↓ | $7.08M↓ | $7.78M |
Peer Comparison
JNJUNHPFE
Fundamentals
The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursin...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.18B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
8.76%
Volume
Today's trading volume
165,921
Recent News
3 Reasons to Sell PNTG and 1 Stock to Buy Instead
The past six months have been a windfall for The Pennant Group’s shareholders. The company’s stock price has jumped 42.3%, hitting $41.70 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
What This Pennant Group Insider Sale Means as Home Health Revenue Surged 43%
Guerisoli exercised stock options and immediately liquidated the position following a 57% one-year rally, while retaining ~104,000 shares worth $4.1 million.
Jim Cramer Outlines Why Pennant Group Stock Can Sail to $55
The Pennant Group, Inc. (NASDAQ:PNTG) was among Jim Cramer’s stock calls on Mad Money, as he advised investors to stick with the largest tech companies in the market. Cramer highlighted the company’s use of AI, as he said: Next, let’s talk about senior housing operators like Pennant Group and National HealthCare Corp. Check out the […]
1 Momentum Stock with Competitive Advantages and 2 We Turn Down
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or even a loyal Reddit fanbase.
The Pennant Group, Inc. (PNTG) Soars to 52-Week High, Time to Cash Out?
The Pennant Group (PNTG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.